Atlas Trials

Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate

Clinical trial NCT05121298 · UNKNOWN

Trial details

NCT number
NCT05121298
Sponsor
Atsushi Kawakami
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid ArthritisJAK InhibitorMusculoskeletal UltrasoundBiomarker
Start date
2021-01-12
Primary completion
2023-11-30
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.